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Abstract
Exceptional aging has been defined as maintenance of physical and cognitive function beyond the median lifespan despite
a history of diseases and/or concurrent subclinical conditions. Since immunity is vital to individual fitness, we examined
immunologic fingerprint(s) of highly functional elders. Therefore, survivors of the Cardiovascular Health Study in Pittsburgh,
Pennsylvania, USA were recruited (n = 140; mean age= 86 years) and underwent performance testing. Blood samples were
collected and examined blindly for humoral factors and T cell phenotypes. Based on results of physical and cognitive
performance testing, elders were classified as ‘‘impaired’’ or ‘‘unimpaired’’, accuracy of group assignment was verified by
discriminant function analysis. The two groups showed distinct immune profiles as determined by factor analysis. The
dominant immune signature of impaired elders consisted of interferon (IFN)-c, interleukin (IL)-6, tumor necrosis factor-a,
and T cells expressing inhibitory natural killer-related receptors (NKR) CD158a, CD158e, and NKG2A. In contrast, the
dominant signature of unimpaired elders consisted of IL-5, IL-12p70, and IL-13 with co-expression of IFN-c, IL-4, and IL-17,
and T cells expressing stimulatory NKRs CD56, CD16, and NKG2D. In logistic regression models, unimpaired phenotype was
predicted independently by IL-5 and by CD4+CD28nullCD56+CD57+ T cells. All elders had high antibody titers to common
viruses including cytomegalovirus. In cellular bioassays, T cell receptor (TCR)-independent ligation of either CD56 or NKG2D
elicited activation of T cells. Collectively, these data demonstrate the importance of immunological parameters in
distinguishing between health phenotypes of older adults. NKR+ T cells and cytokine upregulation indicate a unique
physiologic environment in old age. Correlation of particular NKR+ T cell subsets and IL-5 with unimpaired performance, and
NKR-driven TCR-independent activation of T cells suggest novel immunopathway(s) that could be exploited to improve
immunity in old age.
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Introduction
Older adults aged $65 years have very heterogeneous health
characteristics. They range from the very frail to those with
exceptional physical and cognitive function despite long history of
disease and concurrent subclinical conditions [1,2]. Immunolog-
ically, they range from the immunocompromised to those who
mount vigorous responses to vaccination [3,4,5]. Since immunity
is a determinant of individual fitness, it is reasonable that favorable
health in late life could be mediated by mechanism(s) of immune
homeostasis distinct from that seen at early adulthood to mid-life,
akin to documented differences in immune protective mechanisms
between neonates and adults [6]. This implies normal age-specific
differences in immune physiology consistent with developmental
changes that organ-systems normally undergo through the lifespan
[7,8].
Differences in immune responsiveness between older adults and
younger persons are associated with age-related changes in the T
cell repertoire. Production of new naı¨ve T cells is impaired in older
adults due to the involution to the thymus. Exposure of T cells to
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pathogens through life contributes to the depletion of the naı¨ve T
cell pool and to the overall expansion of memory cells with
contracted diversity of the repertoire of T cell receptors (TCR) due
to the over representation of oligoclonal T cells. Indeed, poorer
antigen-specific responses to the vaccine against seasonal influenza
in the elderly has been recently linked to the contraction of TCR
diversity [9].
There is an emerging biological theme for a secondary level of T
cell diversity with advancing age. Several investigators have shown
increased expression of a variety of natural killer cell-related
receptors (NKR) on T cells of older individuals [10,11]. T cell
clones, verified by identical TCR-CDR3 DNA sequences, that
express different repertoires of NKRs have been isolated from
peripheral blood [12]. In addition, NKRs are co-dominantly
expressed and are found in various combinations on T cells
[13,14,15]. Thus, the aged T cell repertoire could remain diverse
at the level of NKR expression along T cell clonal lineages, in
marked distinction from the repertoire of the young that is diverse
at the level of the clonotypic TCR. In recent work, we reported
that increased expression of the prototypical NKR, CD56, on T
cells with chronologic aging endows functional competence to such
aged T cells [16]. All these observations are consistent with the
idea that the T cell repertoire undergoes remodeling with
advancing age [17]. While there are clear negative immunological
changes with usual chronologic aging [18,19,20], T cell repertoire
remodeling implies that late life survival need not be synonymous
with ill-health or immune incompetence. We suggest that the
nature and extent of repertoire remodeling influences health
outcomes in old age.
To further evaluate this idea of beneficial repertoire remodeling,
we examined a subset of community-dwelling elderly persons who
are survivors of the Cardiovascular Health Study (CHS), called
‘‘CHS All Stars’’ [21]. Given that CHS All Stars elders have a
mean age of 86 years who are surviving ,10 years beyond the
American median lifespan of 77 years [22], we hypothesized that
those who maintain high functional performance would have a
distinctive immunological profile. We sought to identify novel
functionally active T cell subsets and/or humoral factors that
distinguish highly functional elders from those with physical or
cognitive impairment.
Materials and Methods
Protection of human subjects
Human subjects research was conducted in accordance with
principles expressed by the Declaration of Helsinki. Studies
described in this work were in compliance with protocols approved
by the Institutional Review Board of the University of Pittsburgh.
All subjects provided written informed consent, and biological
specimens and all data collected were anonymized.
Subject enrollment, health data collection, and
performance testing
The CHS is a multi-center longitudinal large-cohort study of
5,888 men and women recruited in 1989–90 and an added
minority cohort in 1992–93 [23]. At the Pittsburgh Field Center,
there are 258 survivors of the CHS, called ‘‘CHS All Stars’’, who
were visiting for the 18th year of follow up [21]. Of this group, a
consecutive sample of 140 participants was consented to
contribute additional blood samples for this study. At the time of
this examination, all participants were community dwellers, and
were aged 78 to 94 years with only 2 individuals who were ,82
years old (mean age of 86 years old). Health information were
collected using CHS-standardized protocols that included a
comprehensive characterization of health and function, medical
history and hospitalizations, and self-rating of health [23,24,25].
Demographic information such as age, sex, race, height, weight,
and body mass index were also collected.
All subjects underwent new performance testing of cognitive
and physical ability. Global cognitive function was evaluated by
the modified 100-point scale mini-mental examination (3MSE)
[26]. Physical function was examined by measurements of grip
strength and gait speed [27,28], and by a self-report of difficulty in
performing activities of daily living (ADL), namely; eating,
transferring, dressing, toileting, and bathing [29]. Physical
impairment was defined as self-report of any difficulty with
ADL. Cognitive impairment was defined as having a 3MSE score
of less than 80. ‘‘Impaired’’ status was defined as having either
physical and/or cognitive impairment, and ‘‘unimpaired’’ as
having neither physical nor cognitive impairment [30,31].
As internal reference controls, we also examined banked
specimens obtained from young adults aged 18–40 years that
were part of a previous cross sectional study [16]. These younger
subjects were screened previously for the absence of any current or
historical diagnosis of chronic inflammatory disease, organ
transplant, or malignancy, and/or use of immunosuppressive
drugs, chemotherapy, or oxygen. They served mainly as sources of
peripheral blood mononuclear cells (PBMC) that were used as
calibration control to more appropriately define T cell phenotypes
in flow cytometry procedures, and also as internal positive control
in cellular bioassays. As such, they served solely as internal
instruments for optimizing experimental procedures, rather than
using them as a group to compare functional performance with the
elderly subjects.
Collection of biological specimens
Blood samples were collected during the morning hours; plasma
and cell fractions processed on the same day of collection. Plasma
aliquots were stored in 280uC until use. PBMC were isolated by
standard isopycnic centrifugation over Ficoll gradient, and cells
were stained and analyzed by flow cytometry (see below). Aliquots
of PBMC were also cryopreserved for re-analysis of cell
phenotypes as needed to ensure reproducibility of results, and as
sources of materials for biological assays (see below). As needed,
cryofrozen PBMC were thawed on ice and used immediately.
Plasma samples were similarly thawed and used at no more than
two freeze/thaw cycles.
Analysis of plasma cytokines and anti-viral antibodies
Classical inflammatory mediators such as interleukin (IL)-1, IL-
6, tumor necrosis factor (TNF)-a, and reactant C-reactive protein
(CRP) have been associated with age-related maladies including
physical/cognitive disability [32]. Here, we conducted a global
analysis of humoral factors to examine additional molecules
associated with poorer health, as well as with good health. Assays
for cytokines were performed using Human Cytokine 17-plex
panel kit (BioRad) according to manufacturer specifications.
Cytokine concentrations were obtained using the Luminex 100
system (Luminex Corp). CRP was measured independently by
quantitative enzyme-linked immunosorbent assay (ELISA) using a
commercial kit (R&D Systems).
Seropositivity to cytomegalovirus (CMV) has been reported to
be a predictor of ill-health in some Northern European elderly
populations [33]. Hence, titers of antibodies to CMV, and three
other common viruses, varicella zoster virus (VZV), Epstein-Barr
virus (EBV), and influenza common hemagglutinin (FluHA) in
plasma samples were measured by quantitative ELISA using
diagnostic kits. Anti-CMV titers were determined using CMV
Immune Profiles of Exceptional Aging
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immunoglobulin G (IgG) Enzyme Immunoassay kit (MP Bio-
chemicals); a propriety kit-software was used to generate a best fit
equation (R2$0.95) from which sample anti-CMV titers were
calculated. Anti-VZV and anti-FluHA were measured using VZV
IgG and Flu-IA IgG ELISA kits (Diagnostic Automation),
respectively; quantitative determination of antibody titers was
performed using a lot-specific formula provided by the manufac-
turer. Anti-EBV early antigen (EA) IgG and IgM, and to EBV
Nuclear Antigen (EBNA) IgG were measured using specific kits
(Biotest); quantitative determination of antibody titers achieved
using a standard curve and a best-fit equation (R2$0.95) as
specified by the manufacturer.
Analysis of T cell populations
For this study, leukocyte population analysis was limited to T
cells. Cell phenotypes were examined by multicolor flow cytometry
using a previously described procedure [16]. Briefly, an aliquot of
PBMC were stained with fluorochrome-conjugated antibodies
(BD; Ebioscience; BioLegend; Abcam; Beckman Coulter) to
classical T cell markers TCRab, CD3, CD4, CD8ab, and
CD28; to the adhesion molecule CD57; to the NKRs CD16,
CD56, NKG2D, NKG2A, CD158a, CD158b, and CD158e; to
senescence antigens p16, p53, phospho-cH2AX, and pRB, and to
B cell and monocyte markers CD19 and CD14, respectively, in
order to exclude contamination of T cell populations of interest.
Each cytometry experiment included control cells singly stained
for each molecule, and fluorochrome-conjugated beads for
instrument calibration and for off-line calculation of signal
compensation. Raw cytometry data were acquired using the
LSRII cytometer (BD).
Cytometry data were analyzed offline using FlowJo software
(Tree Star). Signal compensation was applied using the appropri-
ate bead controls. Debris and cell doublet events were electron-
ically filtered out using scatter parameters, and a live lymphocyte
gate was determined using standard forward and scatter signals.
Frequency of cells expressing specific markers was recorded. For
each NKR examined, the density of expression was also measured
as mean fluorescence intensity (MFI) or geometric MFI (GMFI).
The latter was measured so as to minimize effects of counting cells
with extremely high or extremely low receptor density.
Bioassays of T cell function
T cell responses depend on signals from other cellular
components of the immune system. Since chronologic aging is
associated with varying degrees of alterations in the numbers,
phenotypes, and function of immune cell subsets [11,18,19,20],
unfractionated PBMC was used in bioassays in order to minimize
false negative results that could arise from the imbalance of cellular
components when particular cell subsets are removed in the assay.
Considering intrinsic variations of T cell subsets among subjects
[16], this experimental strategy rendered each subject as a control
to itself, and also ensured evaluable number of cells. Another
advantage of this strategy is the utilization of constituent,
unmanipulated, autologous monocytes as surrogate antigen
presentors that bound antibodies or Ig-Fc fusion proteins used
for T cell stimulation, and provided necessary costimulatory
factors.
PBMC were suspended in RPMI 1640 culture medium and
plated out at 12106105 cells/well in 96-well tissue culture plates
with immobilized stimulatory antibodies or IgG controls or
recombinant ligands according to established protocols [34].
Based on empirical experiments, optimal stimulatory conditions
were 1 mg/ml of anti-TCRab (1P26, Biolegend) or anti-CD3
(OKT3, Orthoclone) or anti-CD56 (NCAM, Abcam or C218,
Beckman Coulter), or anti-NKG2D (1D11, Ebioscience), or
10 ng/ml of recombinant NKG2D ligands (R&D Systems),
namely, MIC-A-Fc, ULPB1-Fc, ULPB2-Fc, and ULPB3-Fc
[35]. After 24 hours in tissue culture, cells were harvested. CD4+
and CD8+ T cells were examined for the expression of activation
antigens CD25 and CD69, the granule exocytosis markers
CD107a and CD107b, the cytolytic granules perforin and
granzyme, and the cytokines interferon (IFN)-c and IL-4 by
multicolor flow cytometry (as described above). For the detection
of the latter four cytoplasmic molecules, cultures were incubated
with a monensin-brefeldin A cocktail (Golgi Stop/Golgi Plug, BD)
for 4–6 hours prior to harvest in order to prevent vesicle
exocytosis. For this study, we combined antibodies to perforin
and to granzyme tagged with the same fluorochrome to detect
expression of both cytolytic molecules.
MFI of each of molecules were used to determine the
stimulation index (SI) of cellular response that was calculated by
the formula: SI = (MFI of test sample - background MFI)/MFI of
control. Because the numbers of T cells expressing CD56 or
NKG2D vary between subjects, SI was normalized to the
proportion of CD56+ or NKG2D+ T cells for each subject sample.
Statistical Analyses
All analyses were performed using PASW Version 18 software
(SPSS Inc). Preliminary inter-variable relationships were examined
by Spearman’s rank correlation. Preliminary assessment of
differences between the two pre-defined categorical groups of
subjects, i.e. ‘‘impaired’’ and ‘‘unimpaired’’, was examined by
descriptive statistics including mean, median, mode, range, and
coefficient of variation. Boxplots were used to visualize any
between-group differences. Chi-square test or Mann-Whitney U-
test was used as appropriate to compare group means. For T cell
bioassays, Kruskal-Wallis analysis of variance was used to compare
means of independent variables.
Discriminant function analysis using immune profiles was
performed to evaluate overall confidence for the assignment of
subjects to the two subject-categories. Both simple linear and
stepwise models of subject-group discrimination were evaluated.
To ultimately determine if clusters of immunologic parameters
specifically differentiated the unimpaired group from the impaired
group, factor analysis by Varimax rotation with Kaiser normal-
ization was performed. Whereas a significant cluster in factor
analysis is generally defined by an Eigen value .1.0, we used a
more stringent Eigen value $5.0 to identify principal components
that were more highly significant. Principal components compris-
ing .75% of cumulative Eigen value (CEV) were considered as
main factors that distinguished between the impaired and
unimpaired groups. Those immunologic parameters with rotated
component factor loading coefficient of $0.70 in absolute value
(i.e. those whose correlation with the factor that were at least 0.7)
were identified as those characterizing a factor or cluster.
Subsequently, logistic regression (backward and forward stepwise
models) was performed to generate odds ratios of predictors for
membership in the unimpaired categorical group. Significant odds
ratios were defined with a 95% confidence interval. For all
statistical measures, P-values ,0.05 were considered significant.
Results
CHS All-Star elders exhibit classic features of T cell aging
CHS All Stars elders have a mean age of 86 years (see below),
surviving ,10 years beyond the American median lifespan of ,77
years [22]. Hence, we first examined all subjects for general
features of immune aging in the T cell compartment, namely, the
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irreversible loss of CD28, and the gain of CD57 expression
[36,37]. Since it is not yet known whether or not CD28 loss and
CD57 gain on T cells is controlled by the same or by independent
pathways, we separately analyzed T cell subsets based on
expression of these two antigens.
Figure 1A shows that CHS All Stars elders carried large
populations of CD28null and CD57+ T cells. These unusual
lymphocytes occupied up to 94% and 49% of the total CD8 and
CD4 compartments, respectively. Whereas CD8 T cells showed
clustering of frequencies of CD28null and CD57+ cells, there
appeared a linear, but not significant, correlation between these
two subsets among CD4 T cells. Additional biological indicators of
T cell aging are shown in Figure 1B depicting high number of
CD4 and CD8 T cells that expressed the cell senescence antigens
p16 and p53 consistent with our previous report [16]. Here, we
report that T cells also expressed two other senescence antigens,
pRB and phospho-cH2AX. CD4 and CD8 T cells that
independently expressed these four cell senescence markers
comprised up to 40% of either compartment. There were varying
levels of co-expression of these senescence proteins, but it was not
apparent whether or not there was dominance of one protein over
another.
Aging of human T cells is also accompanied by the increased
expression of the prototypic NKR, CD56 [16]. Figure 1C shows
both CD4 and CD8 compartments of CHS All Stars elders
contained high frequency of CD56+ T cells. Prevalence of CD56+
T cells was concordant with higher proportions of CD28null T cells
in the CD8 compartment compared to the CD4 compartment.
Although it is not yet known whether or not the gains of expression
of CD56 and CD57 on T cells with chronologic aging are co-
regulated, Figure 1D shows direct correlation between the
frequencies of CD56+ and CD57+ T cells in both CD4 and
CD8 compartments. The quantitative levels of expression of CD56
and CD57, measured either as MFI or GMFI as depicted in
Figures 1E–1F, respectively, were also directly proportional.
Characteristics of impaired and unimpaired CHS All Stars
elders
Table 1 summarizes the characteristics of the two categories of
CHS All Stars elders. Consistent with previous clinical assessments
of the larger CHS cohort [38,39,40], All Stars elders had a wide
variety of health characteristics. They had historical and
continuous report of co-morbid conditions. They also had varying
immunization compliance, and self-rating of health. Both groups
had a mean age of 86 years. Blacks, Whites, and both genders
were well represented. Both groups had very similar medical
history. There were unexpected higher reports of incident
cardiovascular disease, diabetes, and arthritis in the unimpaired
group, but only incident arthritis was statistically significant
compared to the impaired group. Nevertheless, the unimpaired
group had significantly higher number who reported with good to
excellent health, and a corresponding significantly lower number
who reported poor to fair health. Notably, the unimpaired group
exhibited significantly better physical performance with higher gait
speed and grip strength measurements.
Value of immunological parameters in assigning CHS All
Stars elders to impaired and unimpaired performance
categories
Data in Figure 1 show that CHS All Stars elders displayed
classic predictable features on immune aging. Therefore, we
inspected whether there were particular immunological parame-
ters (treated as independent variables) that were associated with
the two performance categories of elders. Supplemental data in
Tables S1, S2, S3, S4 show the collated measurements of 12
cytokines, 5 chemokines, 1 acute phase reactant, 6 anti-viral
antibody titers, and 88 T cell parameters. For T cells, specific
subsets were determined based on the expression of CD28, CD57
and seven NKRs.
The collated humoral data (Table S1) showed the impaired
group had significantly higher mean values of granulocyte colony
stimulating factor, IL-6, IL-12p70, and IFN-c. The impaired
group also had higher mean and median values of IL-7, IL-10,
TNF-a, CRP, and macrophage inhibitory protein-1b (MIP-1b),
whereas the unimpaired group had higher mean/median values of
IL-5; but these latter differences did not reach statistical
significance. Regardless of statistical significance, the overall
cytokine environment was characterized by the co-expression of
Th1 (IFN-c, IL-12p70), Th2 (IL-4, IL-5, IL-13), and Th17 (IL-17)
cytokines. In addition, members of both groups were uniformly
seropositive for exposure to CMV, EBV, VZV, and Flu HA.
Overall, CHS All Stars elders showed a normal 3:1 ratio for
classical CD4 and CD8 T cells. They constituted ,62% of CD3+
TCRab+ lymphocytes. The remaining ,38% T cells lacked
expression of both CD4 and CD8, herein referred to as double-
negative or DN T cells (Table S2). CD4:CD8 ratio, and the
proportions of CD4, CD8, and DN T cells were not significantly
different between unimpaired and impaired elders.
The two groups showed certain pairwise differences in some T
cell subsets based on the expression levels of CD28, CD16, CD56,
CD57, and NKG2A. The unimpaired group had significantly
higher mean frequency of CD4 and CD8 T cells that were
CD28null, CD57+, or CD28nullCD56+CD57+. In contrast, the
impaired group showed significantly higher mean frequency of
CD8 and DN T cells that were NKG2A+ (Table S2). In addition,
the unimpaired group had higher mean/median frequency of
NKG2D+ CD4 T cells, and the impaired group had higher mean/
median frequency of CD158a+ and CD158e+ CD8 T cells; but
these differences were not statistically significant.
The observed differences in T cell frequencies between the two
groups were generally concordant with the density of antigen
expression (Table S3 and Table S4). The unimpaired group showed
significantly higher mean MFI or GMFI values for CD16 and
CD57 on CD4 T cells and for CD56 on DN T cells; whereas the
impaired group had significantly higher mean GMFI value for
NKG2A on CD8 T cells. There were also higher mean/median
MFI values for CD158a and CD158e on CD4 and CD8 T cells,
and higher GFMI value for CD158a on DN T cells in the
impaired group. Similarly, there were higher mean/median MFI
values for NKG2D on CD4, CD8, and DN T cells in the
unimpaired group. These latter observations however were not
statistically significant.
Discriminant function analysis was performed to determine
confidence of subject assignment to either the impaired or the
unimpaired group. Figure 2A shows significant separation
between the two groups, with 97.8% of subjects correctly classified
(p,0.026) using each physical, demographic, and immunologic
data point as independent variables in a simple linear model. As
expected, some overlap between the groups was observed in a
stepwise model since the relative significance of each contributing
variable was considered. But despite the overlap, 90.0% of subjects
were deemed correctly classified, with gait speed and subsets of
CD4+CD56+ and CD4+CD28nullCD56+CD57+ T cells as the most
significant contributors to the separation of the two groups
(p,0.0001). As depicted, the two groups appeared to be normally
distributed either to the left or to the right of the centroid (i.e. at
x = 0).
Immune Profiles of Exceptional Aging
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Further stepwise discrimination analysis was performed to assess
relevance of immunologic variables alone in assigning elders to
impaired and unimpaired groups. Figure 2B shows a stepwise
model with 80.0% correct group-assignment based on immuno-
logic variables only. Significant contributors to this model were
granulocyte colony stimulating factor, IFN-c, IL-6, IL-12p70,
frequencies of CD4+CD56+ and CD8+CD158e+ T cells, CD57-
GMFI on CD4 T cells, and NKG2D-GMFI on CD8 T cells
(p,0.0001). Figure 2C shows a stepwise group-separation model
based on T cell subset frequency with 78.7% correct group-
assignment. Significant contributors to this model were
CD8+CD56+ and CD8+CD28nullCD57+ T cells (p,0.003).
Figure 1. CHS All Stars elders display classic features of aging in the T cell compartment. By multicolor flow cytometry, CD3+ TCRab T
cells in PBMC were examined for senescence-associated loss of expression of the costimulatory receptor CD28, and gains of expression of the
adhesion molecule CD57 and the prototypic NKR CD56, as well as the expression of senescence antigens p16, p53, pRB, and cH2AX. (A) Scatter plot
of the frequencies of CD28null and CD57+ cells in the CD4 and CD8 T cell compartments. (B) Representative profiles of p16, p53, pRB, and cH2AX
expression in CD4 and CD8 T cells. (C) Scatter plot of the frequencies of CD28null and CD56+ T cells. (D, E, F) Scatter plot of the levels of expression of
CD56 and CD57 measured as cell frequencies (D), as MFI (E), and as GMFI (F) in the CD4 and CD8 T cell compartments. Solid and dashed lines
represent significant and non-significant regression lines, respectively, with the indicated R2 and p-values.
doi:10.1371/journal.pone.0026558.g001
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Figure 2D shows a stepwise model with 77.0% correct group-
assignment (p,0.0001) based on the levels of expression (GFMI
and MFI) of CD57 and the various NKRs. In this case, major
contributors of separation between the two groups were NKG2A-
GMFI and NKG2D-MFI on CD8 T cells, CD57-GMFI on CD4
T cells, and GMFI/MFI-CD56 on DN T cells. A minor difference
between these T cell phenotype-based models was the broader
range of distribution of discrimination scores in the cell subset-
based model, compared to the narrower score distribution in the
receptor expression-based model.
Figure 2E shows a simple linear model of group-discrimination
with 66.7% correct group-assignment (p,0.02) based on humoral
factors. A stepwise model with 62.7% correct group-assignment
was indicated, but such model did not reach statistical significance.
This was in marked contrast to data in Figure 2B indicating
contribution of humoral factors in a stepwise model for separation
of the impaired and unimpaired groups based on composite
cellular and humoral parameters, suggesting interplay between
humoral and cellular factors.
Distinctive immunologic profiles of impaired and
unimpaired CHS All Stars elders
The notion for the likely interaction(s) of humoral and cellular
factors is line with the well recognized pleiotropic effects of
cytokines and chemokines on various cell types including
lymphocytes [41]. Hence, factor analysis was performed to
determine clusters of T cell and humoral parameters that
distinguished impaired from unimpaired elders. Of the 112
immune parameters measured (Tables S1, S2, S3, S4), six
component factors emerged as distinguishing features for each
group. Table 2 shows that these top six factors accounted for
.75% of the immune profile (indicated as %CEV) of each group.
In both groups, the cellular components of their respective
immune profiles were particular NKRs expressed on various T cell
subsets, i.e. CD4, CD8, and DN. Such T cell subsets were
generally CD28null and/or CD57+ consistent with chronologic
aging (as shown in Figure 1). Whereas cellular factors accounted
for at least 70% of the immune profile of each group, humoral
factors accounted for 5.5% of the group-profiles.
Nevertheless, the two groups had distinct immune profiles
(Table 2). The cellular profile of the impaired group was defined
by CD4, CD8, and DN T cell subsets that expressed inhibitory
NKRs, namely; CD158a, CD158e and NKG2A. CD158a+ and
NKG2A+ T cells (Factors #1, # 3) comprised .39% of the
impaired group-profile. And CD8 T cell subsets that expressed
either CD158e or NKG2A (Factors #5, #6) independently
contributed additional 9.2% and 3.2%, respectively, to the group
profile. In contrast, the unimpaired group had a cellular profile
defined by T cell subsets expressing stimulatory NKRs, namely;
CD16, CD56, and NKG2D. These T cell subsets (Factors #1,
#2, #4) comprised .58% of the unimpaired group-profile. And
CD56-bearing CD4 and CD8 T cells (Factors #3, #5)
independently contributed additional 4.3% and 6.7%, respective-
ly, to the group-profile.
As to humoral components, the cytokines IL-6, IFN-c, and
TNF-a were major constituents of the impaired group-profile. In
contrast, the cytokines IL-12p70, IL-5, and IL-13 constituted the
unimpaired group-profile. Ranking order of the cytokine compo-
nent of the immune profiles were 4th and 6th for the impaired and
unimpaired groups, respectively.
T cell and cytokine predictors of unimpaired phenotype
To further ascertain relevance of cellular and humoral factors in
defining immune fingerprints of the impaired and unimpaired
groups, logistic regression analysis was performed. In this case, the
analysis was conducted identify immune predictors of unimpaired
phenotype. Table 3 shows a stepwise backward logistic model
where seven T cell subsets and two cytokines were identified as
significant predictors of unimpaired phenotype.
Of the T cell subsets, four were positive predictors as indicated by
+b values. Of these predictors, CD4+CD56+CD57+CD28null and
CD4+CD16+ T cell subsets had the highest odds ratios at 3.5 and
1.3, respectively. There were also three additional T cell subsets that
were negative predictors with2b values, namely CD8+NKG2A+ T
cells, CD8+CD28null T cells, and CD4+CD158a+ T cells. The latter
had the lowest odds ratio of 0.131. These data suggested that for
each 1.0% increase in the frequency of CD4 T cells expressing
CD16 or CD56, or each 1.0 MFI/GMFI unit increase in CD56/
CD16 expression, an elder carrying such CD4 T cells would be 1.3
to 3.5 times (or 130% to 350%) more likely be physically/cognitively
unimpaired. And for each 1.0% increased prevalence of
Table 1. Demographic and health characteristics of
functional categories of CHS All Stars elders.
Impaireda Unimpaireda Pb
Total number 58 82
Sex
Male, n 17 30
Female, n 41 52
Race
Black, n 18 31
White, n 40 51
Mean age (SD) 86.2 (3.3) 85.6 (4.0)
Mean height, cm (SD) 158 (11) 161 (9)
Mean weight, lbs (SD) 151 (37) 153 (29)
Mean BMIc (SD) 27.2 (6.6) 27.8 (4.0)
Ever smoke, n (%f) 36 (62.1) 50 (61.0)
Medical history, n (%f)
Any cancer 19 (32.8) 24 (29.3)
Any CVDc 38 (65.5) 56 (68.3)
Type II diabetes 7 (12.1) 15 (18.3)
COPDc 12 (21.7) 14 (17.1)
Arthritisd 26 (44.8) 41 (50.0) ,0.05
Recent vaccination, n (%f)
Influenza vaccine 45 (77.6) 68 (82.9) ,0.05
Pneumococcal vaccine 34 (58.6) 54 (50.0) ,0.05
Self report of health, n (%f)
Poor or Fair 24 (41.3) 23 (28.3) ,0.05
Good to Excellent 34 (58.6) 59 (72.0) ,0.05
Mean gait speed, m/sec (SD) 0.64 (0.1) 0.94 (0.1) ,0.05
Mean grip strength, kg force (SD) 18.1 (0.3) 20.9 (0.4)
a‘‘Impaired’’ was defined by 3MSE ,80 and/or any reported ADL difficulty.
‘‘Unimpaired’’ was defined by 3MSE score $80 and absence of any ADL
difficulty.
bP-values determined by Mann-Whitney U-test.
cBMI, body mass index; COPD, chronic obstructive pulmonary disease; CVD,
cardiovascular disease inclusive of hypertention, angina, incident myocardial
infarction, congestive heart failure, transient ischemic attack, and stroke.
dArthritis inclusive of rheumatoid and osteoarthritis.
fPercent of the subjects within the group.
doi:10.1371/journal.pone.0026558.t001
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CD4+CD158a+ T cells, or each 1.0 MFI/GMFI unit increase in
CD158a expression, an elder with such CD4 T cells would be 0.131
times less likely be physically/cognitively unimpaired; or equiva-
lently, 7.63 times (i.e. 1/0.131= 7.63 or 763%) more likely to be
impaired.
Among the humoral factors, IL-5 and IFN-c were the
significant positive (+b) and negative (2b) predictors of unim-
paired phenotype, respectively. A significantly higher odds ratio at
4.9 was indicated for IL-5 compared to 0.98 for IFN-c. These data
suggested that for each 1.0 pg/ml increase in plasma IL-5, an
elder would be 4.9 times (490%) more likely be physically/
cognitively unimpaired. And conversely, for each 1 pg/ml increase
in plasma IFN-c, an elder would be 1.02 times (i.e. 1/0.98= 1.02
or 102%) more likely to be impaired.
The NKRs CD56 and NKG2D expressed on T cells are
effective drivers of cellular activation
To evaluate biological relevance of the expression of NKRs on
T cells, cellular bioassays were conducted. We focused on CD56
and NKG2D as they are among the constituent NKRs of the T
cell profiles of CHS All Stars elders shown in Tables 2–3.
Specifically, we examined the ability of CD56 and NKG2D to
elicit T cell effector responses independent of TCR triggering.
Results of T cell bioassays are summarized in Figure 3 depicting
cellular outcomes of the independent ligation of CD56 or
NKG2D.
These bioassays showed five significant observations. First,
triggering of CD56 alone or NKG2D alone was sufficient to induce
T cell responses without the need of co-ligation of the TCR. Results
of independent experiments showed that compared to unstimulated
controls, CD56 or NKG2D ligation on T cells resulted in significant
increases in cell surface expression of activation antigens CD69 and
CD25, andmarkers of vesicle exocytosis CD107a and CD107b; and
for increased cytoplasmic stores of cytolytic granules perforin/
granzyme, and cytokines IL-4 and IFN-c.
Second, the magnitudes of TCR-driven T cell responses were
highly variable consistent with well documented inefficiency of
TCR signaling with chronologic aging [20]. TCR ligation elicited
higher levels of responses only in the cases for the expression of IFN-
c, CD25, and CD69 in both CD4 and CD8 T cells. In contrast,
CD56 or NKG2D ligation more vigorously induced expression of
cytolytic granules, vesicle exocytosis markers, and IL-4.
Third, cytolytic activity indicated by expression of granzyme/
perforin, CD107a, and CD107b, whether induced by TCR
ligation or by CD56/NKG2D ligation, was observed in both CD4
Figure 2. Group assignment of CHS All Stars elders based on 3MSE/ADL scores is discriminated by physical and immune
parameters. Discriminant function analysis was performed on collated physical, demographic, and immunological data (see Table 1 and Tables S1,
S2, S3, S4). Using all variables, both simple and stepwise models showed significant separation between impaired and unimpaired groups around the
centroid, indicated as the zero-mark on the x-axis (A). Using only immune variables (B), or T cell subset frequency (C), or receptor density on T cells
(D) stepwise models showed significant separation between the two groups despite some overlap. When humoral factors were used only in the
analysis, only a simple linear model could be constructed (E). Significant contributing variables to models shown in B, C, D were: gait speed (GS); the T
cell subsets CD4+CD56+ (46), CD4+CD28nullCD56+CD57+ (4678), CD8+CD158e+ (8e), CD8+CD56+ (86), and CD8+CD28nullCD57+ (878); GMFI of CD57 on
CD4 T cells (47 g); the GMFI of NKG2D (8 Dg) and NKG2A (8 Ag) on CD8 T cells; the GMFI (N6 g) and MFI (N6 m) of CD56 on DN T cells; the MFI of
NKG2D on CD8 T cells (8 Dm); and the humoral factors GMCSF (GF), IFN-c (IF), IL-6 (L6), and IL-12p70 (L12). The indicated p-values were based on x2
test of Wilk’s lambda discriminant statistic.
doi:10.1371/journal.pone.0026558.g002
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and CD8 T cells. This was an observation consistent with previous
reports that chronologic aging is also associated with novel killing
activity of aged CD4 T cells [36], in contrast to conventional CD4
and CD8 T cells of the young that are considered as helper and
cytolytic cells, respectively.
Fourth, the magnitudes of T cell responses elicited by triggering
of CD56 or NKG2D were not always equivalent. The data
showed that NKG2D ligation induced higher levels of cytoplasmic
stores of IL-4 in both CD4 and CD8 T cells, and IFN-c in CD8 T
cells; and also higher levels of cell surface CD69 in CD4 T cells.
However, activation of the cytolytic machinery indicated by
CD107a, CD107b, and perforin/granzyme was equivalently
induced by the independent ligation of CD56 and NKG2D.
Fifth, NKG2D-mediated responses induced by its ligands MIC-
A and the three ULPBs were also not always equivalent. ULPB3-
NKG2D interaction induced higher levels of CD107b in both
CD4 and CD8 T cells, and higher IL-4 stores in CD8 T cells.
ULBP2-NKG2D interaction induced higher levels of CD69 and
perforin/granzyme in CD4 T cells. And MIC-A-NKG2D
interaction induced higher stores of IL-4 in CD4 T cells.
Table 2. T cell and cytokine profiles of unimpaired and impaired elders.
Unimpaired Impaired
Ranked factor #a T cellb or humoral parameter CEV (%)c Ranked factor #a T cellb or humoral parameter CEV (%)c
1 CD56+CD28null cell frequency, and CD56-MFI/
GMFI in all subsets
15.3 1 CD158a+ cell frequency, and
CD158e-MFI/GMFI in all subsets
26.3
2 NKG2D+ cell frequency, and NKG2D-MFI/GMFI
in all subsets
54.4 2 CD28null cell frequency in CD8
T cells only
45.2
3 CD56+CD57+CD28null cell frequency, CD56-MFI/
GMFI, and CD57-MFI/GMFI in CD4 T cells only
58.7 3 NKG2A+ cell frequency,
and NKG2A-GMFI in all subsets
58.5
4 CD16+ cell frequency, and CD16-MFI/GMFI in all
subsets
63.1 4 Co-existing Th1 (IFN-c, TNF-a)
and Th2 (IL-6)
64.0
5 CD56+CD57+CD28null cell frequency, CD56-MFI/
GMFI, and CD57-MFI/GMFI in CD8 T cells only
69.8 5 CD158e+ cell frequency, and CD
158e-MFI/GMFI in CD8 T cells only
73.2
6 Co-existing Th1 (IL-12p70), and Th2 (IL-5, IL-13) 75.3 6 NKG2A+ cell frequency, and
NKG2A-GMFI in CD8 T cells
76.3
aListed are the top six factors that emerged from Factor (or Principal Component) Analysis with Varimax rotation and Kaiser normalization. The analysis was performed
by parsing T cell and humoral parameters with a level of significance at an Eigen value (EV) = 5.0 or greater. Covariates entered in the analysis were age, gender, and
body mass index. From 112 immune parameters (see text) entered into the analysis, those with rotated loading coefficient of at least 0.70 in absolute value were
considered as those identifying the factor (principal component).
bT cell subsets, i.e. CD4, CD8, and DN, were defined by the frequency cells lacking CD28 and/or expressing CD16, CD56, CD57, CD158a, CD158e, NKG2A, and NKG2D, and
as well as by the actual level of expression of each of the latter seven antigens (expressed as MFI and GFMI; see Materials and Methods).
cCumulative Eigen value; 75% CEV was used as a quantitative cut off to define the composite T cell-humoral profile of the groups.
doi:10.1371/journal.pone.0026558.t002
Table 3. T cell and humoral predictors of ‘‘Unimpaired’’ phenotype.
ba Odds Ratioa Pa
(standard error of b) (95% confidence interval)
T cell subsetsb
CD28null (CD4 only) 0.066 (0.320) 1.068 (1.003–1.138) 0.040
CD56+CD57+ (CD4 only) 0.871 (0.389) 0.419 (0.195–0.898) 0.025
CD56+CD57+CD28null (CD4 only) 1.254 (0.523) 3.503 (1.256–9.769) 0.017
CD158a+ (CD4 only) 22.030 (1.070) 0.131 (0.016–1.070) 0.045
CD16+ (CD4 only) 0.291 (0.088) 1.338 (1.125–1.591) 0.001
CD28null (CD8 only) 20.189 (0.060) 0.828 (0.737–0.931) 0.002
NKG2A+ (CD8 only) 20.057 (0.019) 0.945 (0.911–0.980) 0.002
Humoral parameters
IL-5 1.588 (0.652) 4.894 (1.363–17.57) 0.015
IFN-c 20.02 (0.008) 0.982 (0.967–0.997) 0.021
aThe indicated b-value, odds ratios, and P-values were calculated by logistic regression analysis (in step-wise backward models). Out of 112 immune parameters (see
text) entered in the analysis, data shown were 9 T cell and humoral parameters that were significant in the last regression step. Covariates entered in the analysis were
age, gender, and body mass index.
bT cell parameters refer to combined measurement of cell frequency, and corresponding GMFI/MFI values for CD16, CD56, CD57, CD158a, and NKG2A for the indicated
CD4 or CD8 subset.
doi:10.1371/journal.pone.0026558.t003
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Discussion
Defining exceptional aging by systems approach:
Integration of physical, cognitive, and immunologic
parameters
Measurements of physical and cognitive performance have been
instrumental in refining the concept of exceptional or successful
aging [2,42]. A basic definition of exceptional aging has been
proposed as survival beyond the median lifespan with favorable
health and performance despite a long history of diseases and/or
concurrent subclinical conditions [2]. Since organ-systems develop
and mature at different rates across the lifespan [7,8], exceptional
aging is likely to be mediated by remodeling of physiologic systems
that compensate for the normal loss of cell/tissue structure/
function with age. Indeed, normal chronologic aging invariably
results in structural brain damage including the overall contraction
of white and gray matter volumes. But despite such overt damage,
some elders can still retain executive brain function due to
compensatory higher functional activity of the right posterior
parietal cortex [43]. Similarly, advancing age normally results in
muscle fiber atrophy and in reduced numbers of motor units that
contribute to physical disability. But some elders can still retain
physical function with optimal motor endplate conduction due to
compensatory increases in the numbers of muscle fibers per motor
unit, of pre-synaptic nerve terminal branches, and of post-synaptic
neurotransmitter receptors [44]. Thus, there is not only age-
Figure 3. NKRs CD56 and NKG2D expressed on T cells are competent receptors that induce activation of T cells independent of
TCR-derived signals. Induction of cell surface expression of activation antigens (A) CD25 and (B) CD69, markers of granule exocytosis (C) CD107a
and (D) CD107b; and of cytoplasmic stores of (E) cytolytic proteins (combined staining for perforin and granzyme), and the cytokines (F) IL-4 (G) IL-
17, and (H) IFN-c in CD4 and CD8 T cells in response to 24-hr incubation in anti-TCRab, or anti-CD56, or anti-NKG2D, or recombinant NKG2D ligands
MIC-A, ULPB-1, ULPB-2, and ULPB-3. Data shown are means (box) and standard deviations (whiskers) from 13-17 randomly selected unimpaired
subjects. P-values of all of the measured cellular responses were significant (p,0.05, Kruskall-Wallis analysis of variance).
doi:10.1371/journal.pone.0026558.g003
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related beneficial remodeling in brain and in muscle, but that
remodeling appears coordinated as evidenced by the tight
association of physical and cognitive ability in prognosticating
long-term functional independence and mortality among old
people [45,46].
We have postulated that the immune repertoire may also
undergo remodeling with age [17]. As immunity is a determinant
of individual fitness, of interest is whether continued physical and
cognitive function among elders is linked to an immunological
profile distinct from those with poorer performance. Hence, we
examined CHS All Stars elders who represent a group of highly
functioning, community-dwelling elders with a late life trajectory
towards either continued good health or slow functional decline
[21]. Such life trajectory of this group of elders is based on results
on continuous clinical monitoring spanning nearly two decades
[42].
In this study, we defined two categories of CHS All Stars elders
based on ADL and 3MSE performance scores. ADL and 3MSE
are global measures of physical and cognitive functions, respec-
tively, that have proven to be useful in distinguishing groups of
elderly people with either intact function or those with mild
disability in large cohort studies [30,31]. Despite the relatively
small number of CHS All Stars subjects (n = 140) examined in this
study, along with their wide variations of medical history (Table 1),
our data show that physically and cognitively unimpaired or
impaired elders are identifiable. Confidence for this 3MSE/ADL-
based categorization of CHS All Stars elders is provided by the
observed group-differences in both gait speed and grip strength.
The latter two physical parameters have been validated as
independent predictors of long-term function and eventual
mortality in the elderly [27,47].
Consistent with their mean age of 86 years, CHS All Stars elders
display the predicted biological indicators of aging in the immune
system (Figure 1). Their T cell repertoire consists of large
populations of CD4 and CD8 T cells lacking expression of CD28
with corresponding gain of expression of CD57 [36,37]. Such T
cells variably express p16, p53, cH2AX and pRB, proteins
expressed by somatic cells that are in advanced stages of
senescence [48,49,50]. CHS All Stars elders also have a global,
low-level upregulation of several plasma cytokines and chemokines
(Table S1) in addition to IL-1, IL-6, TNF-a, and CRP. Low level
elevations of the latter four molecules have been the basis for the
idea that chronologic aging promotes elaboration of an adverse
inflammatory milieu [51], with IL-6 as the most consistent
predictor of disability in many elderly populations [32]. But
considering the many possible sources of these humoral factors,
and their pleiotropic effects including immune-enhancing and
pathological properties, we reasoned that immune profiles of
highly functioning CHS All Stars elders would more likely consist
of a combination of humoral and cellular factors rather than a
single factor.
Our data show that T cell and humoral parameters are key
variables in parsing the two groups of CHS All Stars elders. Such
parameters account for 60% to 80% of the separation between the
unimpaired and impaired groups (Figures 2B–2E). And combin-
ing the same parameters with physical performance measures of
gait speed and grip strength account for more than 90% of the
separation between the two groups (Figure 2A). Moreover, we
found that 6 composite T cell and humoral factors, out of the 112
immunological parameters measured (Tables S1, S2, S3, S4),
differentiate unimpaired elders from those who are physically/
cognitively impaired. Our confidence on the identification of these
T cell and humoral components of the group-immune profiles
came from two independent analytic procedures, namely; factor
analysis (Table 2) and logistic regression modeling (Table 3).
Global systemic cytokine upregulation in old age
deviating from the Th1-Th2-Th17 paradigm
In line with previous studies [32], our data show that the
impaired group is associated with the dominance by TNF-a and
IL-6 (Table 2). IFN-c is also part of this impaired group profile,
suggesting a cytokine environment in the impaired group is Th1
dominant. This is an unexpected finding since IFN-c is an
immune-enhancing cytokine that promotes normal anti-viral
activities of monocytes, tissue macrophages, and cytotoxic T cells
[52]. However, IFN-c is also a potent inhibitor of cell proliferation
[53], a property that is perhaps consistent with its inclusion in the
impaired group-immune profile.
In contrast, the unimpaired group-humoral profile is associated
with two Th2 cytokines IL-5 and IL-13 (Table 2), although IL-5 is
a stronger positive predictor of the unimpaired phenotype
(Table 3). The group-profile includes co-expression of IL-4 (Table
S1). Considering that IL-4 is a regulator of IL-5 and IL-13
production that in turn positively feedback IL-4 production [54],
these data indicate a likely dominant Th2 cytokine environment in
the unimpaired group. This suggestion is supported by the fact
that IFN-c, a Th1 cytokine, is a negative predictor of unimpaired
phenotype (Table 3). We also found that IL-12p70, a known
upstream regulator of IFN-c, is part of this unimpaired humoral
profile (Table 2).
Nevertheless, it is important to note that the seeming Th2 versus
Th1 dominance in the unimpaired and impaired group,
respectively, are within environments where there are in fact
sufficient amounts of Th2 (IL-4, IL-5, IL-13) and Th1 (IFN-c,
IL12-p70) cytokines (Table S1). This is in contrast to the Th1/Th2
paradigm where normal immune responses reportedly skew to
either one Th-environment, but not the co-occurrence of Th1 and
Th2 cytokines, because the two Th pathways counter regulate
each other. Thus, it would be of interest to examine whether the
physiologic cytokine environment in old age is an exception of this
Th1/Th2 paradigm since there is also concurrent IL-17 (Th17)
(Table S1), although the latter is not significantly associated with
either impaired or unimpaired groups. An intriguing notion is
whether this prevailing ‘‘mixed’’ Th1, Th2, and Th17 environ-
ment is essential to lymphocyte homeostasis so as to prevent
lymphopenia since neither the thymus nor the bone marrow of the
aged are producing any more new lymphocytes. Perhaps more
interestingly, it would be of interest to examine whether
concurrent Th1, Th2, and Th17 cytokines, rather than skewing
towards one Th-type, is more critical in mounting immune
responses in old age. Unraveling how balance of Th cytokines is
achieved in old age remains to be examined.
Anti-viral serology is not a significant contributor of
immune profiles of old age
Our data show that all the elders examined have generally high
titer antibodies to CMV as well as to VZV and to two EBV
antigens (Table S1). This is in stark contrast to reports that CMV
seropositivity is, by itself, a predictor/indicator of poor health and
mortality in some Northern European elderly populations [33].
These differences in experimental results could be related to the
rate at which different populations become exposed to CMV.
Whereas CMV exposure among Europeans seems to occur more
gradually through the lifespan leading to peak CMV seropositivity
in late life [55], there is more widespread CMV seroprevalence
among Americans due to CMV exposure at an earlier age [56]. A
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recent study [57] indicates that CMV seropositivity is indeed an
insufficient measure of health risk for elderly Americans. However,
it may still be of interest to also examine whether the observed lack
of association between anti-CMV titers with the two categories of
CHS All Stars elders could indicate anti-CMV immunity in this
group of elderly Americans. A further study is therefore needed to
examine causal relationships between CMV reactivation, CMV
viral load, anti-CMV antibody titers, CMV-specific T cells, and
functional performance.
Unique subsets of NK-like T cells in old age
Lending support to the idea about repertoire remodeling in old
age [17], our present data show that unimpaired and impaired
CHS All Stars elders are distinguished by the preponderance of
particular subsets of CD4, CD8, and DN T cells bearing
stimulatory and inhibitory NKRs, respectively (Tables 2, 3). As
indicated, the DN subset expressed neither CD4 nor CD8, and
whether DN cells were derived from cells that lost CD4 or CD8
expression is unknown at this time.
The dominant stimulatory NKRs expressed on T cells include
NKG2D, CD16, and CD56. And the dominant inhibitory NKRs
expressed on T cells include NKG2A, CD158a, and CD158e.
CD16 and CD56 are the prototypic NKRs that are normally used
to identify NK cells. Although it remains to be examined how
expression of these individual NKRs is regulated in aged T cells,
increased expression of NKRs on T cells with advancing age is
likely to be genetically programmed. We have reported differences
in the fine regulation of particular NKRs between T cells and NK
cells [58]. We have reported the results of a cross sectional study
documenting the increased expression of CD56 on T cells with
chronologic aging [16]. And studies comparing examining
‘‘young’’ and ‘‘old’’ groups, the latter usually defined by the age
of 60 years and older, also document varying higher levels of
expression of the various NKRs on T cells among older persons
[10,14]. Our present data constitute the first evidence for the
association between stimulatory and inhibitory NKRs expressed
on T cell subsets with functionally unimpaired and impaired
elders.
Unique pathways of TCR-independent activation of T
cells of the aged
For conventional NK cells, stimulatory and inhibitory NKRs
signal either activation or suppression of NK effector differenti-
ation, respectively. Considering that advancing age is associated
with losses of classical NK and T cell function [11], dominance of
stimulatory NKRs on aged T cells could be a way to rescue age-
related signaling inefficiency of the classical TCR [20] and help
maintain cell-mediated immune responses in old age. Along these
lines, our present data show stimulatory NKRs CD56 and
NKG2D are indeed signaling-competent receptors for T cell
activation (Figure 3). We focused on CD56 since the function of
this NKR is not yet known, unlike CD16 that is a validated NK
cell signaling receptor [59]. We also examined NKG2D since it is
a receptor known recognize viral epitopes including CMV [35],
albeit NKG2D-CMV interaction was not examined here.
Nonetheless, our data show that ligation of either CD56 or
NKG2D, independent of TCR ligation, can result in various
cellular outcomes including expression of activation antigens
(CD25, CD69), cytolytic granules, and cytoplasmic stores of IL-4
and IFN-c as well as granule exocytosis (indicated by the cell
surface expression of CD107a/b). We should note that the cellular
bioassays here were aimed at demonstrating the functional
competence of CD56 and NKG2D as an independent receptor
on T cells. A comparison of the magnitudes of CD56-/NKG2D-
driven T cell responses between unimpaired and impaired elders
still remains to be examined, an undertaking that may require a
much larger cohort.
Remarkably, our data show magnitudes of CD56/NKG2D-
driven responses can even be higher than similar responses driven
through TCR ligation. Whether the CD56/NKG2D-driven
expression of IL-4 and IFN-c contributes to the observed systemic
upregulation of these two cytokines (Tables 2,3) will have yet to
be examined. Similarly, the cellular significance of the expression
of inhibitory NKRs NKG2A, CD158a, and CD158e on aged T
cells remains to be evaluated as we had limited blood specimens to
conduct multiple replicate bioassays for both stimulatory and
inhibitory NKRs. However, dominance of inhibitory NKRs on
aged T cells could either indicate continued malfunction of the
aged T cells, or perhaps an adaptation to control autoreactive T
cells in old age [60]. Thus, it remains to be determined whether
stimulatory and inhibitory NKR expression on the same T cell
counter regulate each other, or that allosteric dominance of one
type of NKR would determine the eventual effector function of the
NKR-bearing T cell. It also remains to be examined whether the
stimulatory NKRs can potentiate TCR-derived signal, which has
been documented to be either inefficient or defunct in aged T cells
[20].
In summary, results of the present cross sectional study
demonstrate the value of immunologic parameters in combination
with measures of physical and cognitive performance in defining
resilience and healthy aging in older adults. Association between T
cell subsets expressing stimulatory NKRs, systemic IL-5, and intact
functional performance, and conversely, association between
inhibitory NKRs, IFN-c, and mild disability suggest divergent
immunopathways. Further elucidation of these pathways will
provide better understanding of what constitutes immune
competence or incompetence in old age. Longitudinal studies
involving follow up of subjects across the lifespan are needed to
determine factors that drive elaboration of NKRs on T cells and
systemic upregulation of IFN-c and IL-5. Such studies would also
be an opportunity to examine whether and how changes in health
and performance might modify expression of these immune-
related molecules, or alternatively, to determine whether modu-
lation of expression of these molecules could have direct impact on
health in old age.
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